Member Info for Toyin

Thank you Elric, much appreciated.

Ody, your research is extremely poor, hence your points are laughable.

1. His (the boards) target was missed because they had included the distribution deals which they didn’t take.
2. Sales are increasing, maybe not significantly but Stuart has always said he isn't going to throw loads of cash at marketing as we are not a b2c.
3. The results were not delayed, they came within the aim rules. Yes they where later than last year, but that has been explained a thousand times.
4. There has been marketing spend but it has been limited as we are not a b2c
5. If there is no social media staff, who is responsible for this, https://linktr.ee/axisbiotix
6. The only reason communication is poor is if you do no research. There are plenty of interviews/information if you put some effort in.

Ody, I dont know what to say about that apart from agree with Mad's view.

What has been woeful and amateurish? The fact he got a product to market over 12 months ahead of schedule?

The fact he decided not to take distribution deal's and wait for a better long term option for all concerned?

The fact he's done a raise to support ongoing developments and a potential acquisition that would fast forward us to profitability, help with product development and strength our discussions with the multinationals?

I'm not saying its been plain sailing but it never is, if it was, you wouldn't need a ceo!

https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-51e

mol, what is the point of your exercise?

oleric, you want important questions answering and instead of directing those questions in the right direction, you come on here complaining that they haven't been answered, how does that expertise help anybody?

Lay off the mushrooms fella!

oleric, if you have important questions send them to the company, I'm sure they will answer them where possible. Having said that, if you will not be buying at this point it would be a waste of time, as would posting on a share you do not hold.

https://youtu.be/VmxC4o_SmOk

Glad most are coming back down to earth.

Mad, you make excellent points again. I would also add if we acquire a profitable entity we give up future EIS/VCT, so I suggest this must be a blinding deal for SA to forfeit that.

rebarm, no I don’t know that nothing has been sold by Croda. I will wait for the rns. What I do know is, Croda signed a deal 3 years ago, have spent circa £5m, have found enhanced benefits and SA has a meeting in January and we expect revenue in 2023. I’ll take my chances for another few weeks.

thomas, Croda has got nobody by the balls. We get paid a set percentage on ingredients sold. We aren’t dealing with Ronnie and Reggie!

Aquae, this is exactly what I’m talking about, I pull you on one point. You say:

“Regarding the potential acquisition, I think we can all guess the current value of that company if it is change out of the hoped for £2.5M fund raise.”

Please pay special attention to the last sentence.

Acquisition strategy

The Group is in ongoing discussions to acquire a private company that provides a variety of branded topical products for common dermatological conditions such as psoriasis and eczema to NHS hospitals, dispensing practices and retail pharmacies. The proposed target is profitable and the Group sees a number of synergies to improve this. However, there is no certainty of timing or execution as the Company would need to agree additional funding using debt and/or equity and any acquisition would be conditional on satisfactory diligence.

If investors aren’t happy, fine, sell up and move on, but before you do read the rns properly before blowing a gasket.

Thomas, with respect, what?

Thanks Mad, sounds like a good summary.

I have read it a couple of times but need to digest, i'm not as quick at coming to conclusions as sum, especially Phat, he was out the blocks within 5 minutes! Most intrigued about the possible acquisition. I wont be jumping to a conclusion until I have more colour and context. Initial thoughts, i'm certainly not upset or panicking.

Phat, how do you know it was a mistake, do you have information the rest of us don't? Please elaborate.

Can you define right, what do you exactly mean?

oleric, you say there is no acceptable proof, says who, you! There is lots of proof, just because you decide to ignore it that's your problem. Your argument is anchored to a clinical trial and I have explained why the co didn't go down that route. They cant make any claims because they haven't done a trial, we have known this from the beginning, why do keep going on about it. By the way, I'm very glad they didn't because my psoriasis is completely gone.

Anyway you dont need a pleb like me telling someone as wise and as experienced as yourself how wrong you are, so I suggest you sell up and be on your way oh great one.

I won’t get into the tit for tat, but what I will comment on is the rubbish oleric spouts.

oleric says

"at least the company is alleviating the condition"...Well this may or not be true but what we do know is that the company cannot associate their product with such a statement because the lack of clinical evidence supporting it.

1. It is 100% true that AxisBiotis-Ps, does without doubt alleviate the condition of psoriasis, this is a fact.

2. Sbtx have not gone down the clinical route because then the product would be classified as Pharma and could only be sold via prescription.

I’m not saying the Pharma route will never happen, just pointing out the downside.

Clio, I would suggest the amount of money that is involved, MN’s will not share one crumb with any other entity outside of sbtx, irrespective of how the product is delivered.

That’s fair Clio. He must have had good reason at the time, like you say he is frugal, maybe it was linked in with the distribution deals.

Clio, what do you mean, “the clock is now ticking”?